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Abstract  
Apitherapy is the medicinal therapeutic use of honeybee products, consisting of honey, propolis, royal jelly, 
pollen, beeswax and, in particular, bee venom. The aims of this paper were to review bee venom and its 
therapeutic values. Bee venom therapy is the therapy which utilizes the application of bee venom to treat various 
diseases and it has been used since ancient times in traditional medicine. Bee venom is produced by  the venom 
gland located in the abdominal cavity and contains several biologically active peptides, including melittin (a 
major component of BV), apamin, adolapin, mast cell degranulating peptide, and enzymes (phospholipase A2, 
and hyaluronidase) as well as non-peptide components, such as histamine, dopamine, and norepinephrine. Bee 
venom has therapeutic values against variety of disease like Arthritis, nervous system diseases, heart and blood 
System abnormalities and for skin disease. Furthermore, Bee venom has been widely used in the treatment of 
some immune-related diseases, as well as in recent times in treatment of tumors. Several cancer cells, including 
renal, lung, liver, prostate, bladder, and mammary cancer cells as well as leukemia cells, can be targets of bee 
venom peptides such as melittin and phospholipase A2. In order to benefit from the promising role of bee venom 
therapy research should be extended to identify their specific component and target action. 
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1 INTRODUCTION 
Use of honey and other bee products can be also traced back thousands of years and healing properties are 
included in many religious texts including the Veda, Bible and Quran (Lee et al., 2005; Adewole et al., 2015). 
Apitherapy is the medicinal therapeutic use of honeybee products, consisting of honey, propolis, royal jelly, 
pollen, beeswax and, in particular, bee venom (BV) (Lee et al., 2005; Ali, 2012). Bee venom (BV) therapy which 
utilizes the application of bee venom to treat various diseases has been used since ancient times in traditional 
medicine (Liu and Tong, 2003; Lee et al., 2005; Ali, 2012; Silva et al., 2015). It is based on the fact that these 
crude extracts exhibit a wide variety of pharmacologically active molecules. This pool of chemical compounds is 
formed by biogenic amine, enzymes (phospholipase A2), basic peptides and proteins (melittin and apamin) and a 
mixture of water-soluble and nitrogen-containing substances (Santos et al., 2011; Silva et al., 2015). 
Bee venom contains a variety of different peptides, including melittin, phospholipase A2, apamin, 
adolapin, and mast cell-degranulating peptide (MCDP) (Kwon et al., 2002; Park et al., 2004). Among these 
compounds, melittin, a small linear peptide consisting of 26 amino acids, is the major component of bee venom 
(Wang et al., 2009). Depending on the disease being treated, BV therapy can be used by applying a cream, 
liniment, or ointment, via injection, acupuncture or even directly through a live bee sting (Ali, 2012). The most 
commonly used method is bee venom acupuncture (BVA), which involves the injection of diluted bee venom 
into acupuncture points. It can be employed as an alternative medicine in patients with PD, pain and other 
inflammatory diseases, such as rheumatoid arthritis and osteoarthritis (Lee et al., 2005; kim and Jeon, 2014).  
Bee venom has been used as a traditional medicine to treat back pain, rheumatism, and skin diseases by its 
antibacterial, antiviral, and anti-inflammatory effects (Park et al., 2010; Wang et al., 2009). Moreover, several 
studies have demonstrated that bee venom and/or melittin have anti-cancer effects including prostate, liver, 
breast, cervical, renal (Park et al., 2010a) cancer cells. Interestingly, BV has also been used in humans to treat 
neurological diseases with neuroinflammatory aspects, such as multiple sclerosis and Parkinson’s Disease (Park 
et al., 2010; kim and Jeon, 2014) 
Currently, several treatments for disease like cancer are very costly and have numerous side effects. 
Due to this anticancer drug developments from natural resources are ventured throughout the world. Venoms of 
several animal species including bee have shown promising therapeutic potential against cancer. Therefore, the 
objective of this paper is to review recent article regarding bee venom and its therapeutic values. 
 
2 Properties and Composition of Bee Venom 
Honeybee venom is a  transparent liquid dries up easily even at room temperature, odourless, ornamental 
pungent smell, a bitter taste, hydrolytic blend of proteins with basic pH (4.5 to 5.5) that is used by bees for 
defense. When coming into contact with mucous membranes or eyes, bee venom causes considerable burning 
and irritation. Bee venom is soluble in water and insoluble in alcohol and ammonium sulfate. When it comes in 
contact with air it forms grayish-white crystals. Dried venom takes on a light yellow colour and some 
commercial preparations are brown, thought to be due to oxidation of some of the venom proteins. Bee venom 
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contains a number of very volatile compounds which are easily lost during collection, it is considered a rich 
source of enzymes, peptides and biogenic amines, it is specific weight 1.1331 (Ali, 2012). The bee venom 
contains 88% water. The glucose, fructose and phospholipid contents of venom are similar to those in bee's 
blood (Bogdanov, 2015) 
Bee venom is a complex mixture of proteins, peptides and low molecular components. Nowadays its 
components have been characterized. The main components are proteins and peptides. The composition of fresh 
and dried BV differs mainly in regards to the volatile components; the overall biological activity is similar 
(Zolfagharian et al., 2015; Bogdanov, 2015). 
 
2.1 Polypeptides 
Bee venom contains a variety of peptides, including melittin, apamin, adolapin, the mast-cell-degranulating 
peptide, enzymes (phospholipase A2) biologically active amines (i.e. histamine, epinephrine), and a non peptide 
components with pharmaceutical properties (Roy et al., 2015). Polypeptides are smaller in molecular weight than 
enzymes, made of 2 or more amino acids. BV has numerous polypeptides, the main one being melittin, which is 
also the main component of BV. Melittin has a MW of 2840 daltons but it can reach 12500 daltons because it 
can be also in a tetrameri form (Bogdanov, 2015). 
 Peptide is a potent anti-inflammatory agent; however, at low concentration it is a strong mediator of 
mast cell degranulation and histamine release from mast cells, which are present in the blood supply and in all 
tissues perfused by blood. (Ziai, 1990; Moreno and Giralt, 2015) Bradykinin is a physiologically active peptide 
that belongs to the kinin group of proteins. Bradykinin and related kinins act on two receptors, designated as B1 
and B2. The former is expressed only as a result of tissue injury and it is thought to play a role in chronic pain. In 
contrast, the B2 receptor is constitutively expressed, participating in vasodilatation via the release of prostacyclin, 
nitric oxide, and endothelium-derived hyperpolarizing factor, thus contributing to lowering blood pressure 
(Sharma, 2014). Adolapin is a peptide that was first isolated from bee venom in the 80s. It exerts a potent 
analgesic effect and anti-inflammatory activity in rats, blocking prostaglandin (Moreno and Giralt, 2015) 
 
2.2 Enzymes 
When focusing on enzymes related to toxicity, phospholipase and hyaluronidase are the two major enzymatic 
proteins present in hymenoptera venom. These enzymes can trigger an immune response, inducing IgE response 
in susceptible individuals (Cichocka, 2012). Phospholipase A2 (PLA2) is a calcium-dependent enzyme that 
hydrolyzes the sn-2 ester of glycerophospholipids to produce a fatty acid and a lysophospholipid. It destroys 
phospholipids, disrupting the integrity of the lipid bilayers, thus making cells susceptible to further degradation. 
In fact, PLA2 reaction products, such as lysophosphatidylcholine, lysophosphatidic acid and sphingosine 1-
phosphate, can have cytotoxic or immunostimulatory effect on diverse cell types, causing inflammation and 
immune responses (Gräler, 2012). 
Hyaluronidase is commonly known as a “spreading factor” because it hydrolyzes the viscous polymer 
hyaluronic acid into non-viscous fragments. When extracellular matrix is destroyed by hyaluronidase, the gaps 
between cells facilitate the invasion of venom toxins. Therefore, venom penetrates tissues and enters blood 
vessels, thus catalysing systemic poisoning. Furthermore, hydrolyzed hyaluronan fragments are pro-
inflammatory, pro-angiogenic and immunostimulatory, thus inducing faster systemic envenomation Girish, 
2007). 
 
2.3 Low molecular compounds 
BV contains smaller quantities of low molecular compounds are different in nature: amino acids,  
catecholamines, sugars and minerals (Zolfagharian  et al., 2015; Bogdanov, 2015). These small molecules are 
minerals, amino acids, and physiologically active amines, such as catecholamines. Among this category, 
histamine is one of the major components. This organic nitrogenous compound participates in the inflammatory 
response by increasing the permeability of capillaries. In a similar manner, the catecholamines dopamine and 
nor-adrenaline increase heartbeat, thereby enhancing venom circulation and thus, its distribution. However, like 
histamine, the effects of these two catecholamines are largely overshadowed by those of other components of 
venom. Serotonin can act as an irritant and can contribute to the pain caused by the venom. Finally, high levels 
of acetylcholine are detected only in wasp venom. Acetylcholine can increase perceived pain of a sting by 
stimulating pain receptors synergically with histamine effects (Moreno and Giralt, 2015). 
 
3 THERAPEUTIC VALUES OF BEE VENOM 
BV is a well-known pharmacologically active product of the hive synthesized by the venom glands associated 
with the sting apparatus of worker and queens, stored in the venom reservoir, and injected through the sting 
apparatus during the stinging process (Schmidt and Buchmann, 1999). Due to its anti-oxidants, anti-coagulants, 
anti-inflammatory properties and bioactive substances like melittin and phospholipase BV mainly used to treat 
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many inflammatory disorders such as arthritis, cancer, diseases of nerveous system, heart and blood system 
abnormalities, skin diseases and others (Castro et al., 2005). Furthermore, therapeutic application of bee venom 
include their use in the management of bursitis, tendonitis, dissolving scar tissue, in the management of post-
herpetic neuralgia, Lyme disease, rheumatoid arthritis, osteoarthritis, multiple sclerosis, TMDs and more (Ram 
et al., 2014). 
 
3.1 BV Against Arthritis  
Bee venom(BV) uses in treating arthritis by blocking the building of the pro inflammarory substances cytokinine, 
PGE-2, NO, Tumor Necrosis Factor TNF-2 and Enzyme COX-2, and inhibiting the proliferation of rheumatoid 
synovial cells (Krylov et al., 2007). After applying different methods of venom administration like: bee stings, 
api-puncture, injections, electrophoresis and application with ultrasound waves (phonophoresis); good success 
rates lying between 60 and 90 % have been achieved (Son et al., 2007). In last 10 years api-puncture has been 
developed as a new technique for treating arthritis (Urtubey, 2005). Additionally, bee venom does not influence 
rheumatoid deformation, as shown by patients X-rays, but it acts by controlling pain and inflammation (Krylov 
et al., 2007). Furthermore, BV also use in the treatment of different pain conditions: Neck pain, low back pain, 
herniated lumbar pain, and disc pain, shoulder pain after stroke, acute ankle sprain, wrist sprain, rheumatoid 
arthritis and knee osteoarthritis while  bee sting(BS)  and api-puncture (AP) therapy are proved to be useful in all 
these conditions ( Lee  et al., 2005). Researchers claim that bee venom therapy is better than hormone therapy; 
as hormone therapy causes unfavorable side effects such as the reduction in the activity of these vital hormone 
glands, while the BV constantly activates the activity of hormonal systems (Bogdanov, 2015) 
 
3.2 BV Against Cancer 
BV has anti-cancer activities, due mainly to two substances that have been isolated and characterized: melittin 
and phospholipase A2 (PLA2). Although melittin and PLA2 are the two major components in the venom of the 
species Apis mellifera and many studies have describing their antitumoral effects (Ownby et al., 1997). BV acts 
against different types of cancer in cell as melittin; a powerful anticancer peptide might be the better choice than 
whole BV (Orsolic, 2005). Melittin is multifuctorial ingredient in BV that diminishes surface tension of 
membranes and stabilises them, exerts anti-inflammatory  activity in very small doses, stimulates smooth 
muscles, activates the hypophysis and adrenal glands; increases capillary permeability increasing blood 
circulation and lowering the blood pressure, lowers blood coagulation, immunostimulatory and 
immunosuppressive, radiation protective, influences the central nervous system,anticancer (Bogdanov, 2015). 
On the other hand, bee venom acupuncture and melittin were used to control neuropathy caused by cancer 
chemotherapy (Park, 2010). Moreover, bee venom peptide lasioglossin II exhibits cytotoxic activity against 
various cancer cells in vitro (Park et al., 2012; Bandyopadhyay et al., 2013). 
 
3.3 BV Against Nervous System Diseases 
BV has different effects on the central and peripheral nervous system and used for the treatment of different 
neurological conditions such as Multiple Sclerosis (MS), amyotropic lateral sclerosis (ALS) Alzheimers and 
Parkinson (Hwang et al, 2015). Changes in Glutamate, the predominant excitatory neurotransmitter in the central 
nervous system, alters the activity of glutamate transporters in many neurodegenerative diseases, including 
Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (Hauser et al., 2001). But BV is 
helpful in reducing glutamatergic cell toxicity in neurodegenerative diseases as it protects cell death and 
significantly inhibits the cellular toxicity of glutamate, and pretreatment with BV altered MAP kinase activation 
following exposure to glutamate (Lee et al., 2011). 
 
3.4 Therapeutic Effects of BV on Heart and Blood System Abnormalities 
BV increases coronary and peripheral blood circulation, improves the blood microcirculation ,slows down heart 
at lower doses and stimulates it at higher ones, lowers blood pressure, antiarhythmic against blood coagulation 
and  fibrinolytic, stimulates the building of erythrocytes (Savilov, 2010). It also uses in alleviations of 
hypertension, arteriosclerosis, endarteritis (chronic inflammation of the inner layer of arteries) angina pectoris 
arrhythmia (Krylov et al., 2007). 
 
3.5 Therapeutic Effects of BV Againt Skin Disease  
Researchers claimed that BV has therapeutic effects against many skin diseases like eczema, dermatitis, psoriasis 
furunculosis (recurring boil), cicatrices, baldness, acne and other diseses (Kim et al., 2015) other disease such as: 
opthamology, gastroentorology: colitis, ulcers, pulmonology: asthma, bronchitis, otorinolaringology: pharingytis, 
tonsillitis, ear nerveneuritis, endocrinology, urology, gynecology (Hegazi et al., 2012). 
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4 Conclusion 
Apitherapy is the use of honey bee products for medical purposes whereas; bee venom therapy is the use of live 
bee stings (or injectable venom) to treat various diseases. Bee venom is a complex mixture of proteins, peptides 
and low molecular components. The main components are proteins and peptides. Therapeutic application of bee 
venom include their use in the management of bursitis, tendonitis, dissolving scar tissue, in the management of 
post-herpetic neuralgia, Lyme disease, rheumatoid arthritis, osteoarthritis, multiple sclerosis, TMDs and more. In 
order to benefit from the promising role of bee venom therapy research should be extended to identify their 
specific component and target action. Although, bee venom is safe for human treatment; it should only be used 
under the supervision of a qualified health care professional.  
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